U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288229) titled 'The Benefits of Wearable AI in Post-Discharge Management of AMI Patients' on Nov. 14.
Brief Summary: Myocardial infarction (MI) remains a major threat to human health. Although interventional treatment techniques have advanced rapidly, many patients still experience major adverse cardiovascular events (MACE) and require hospital readmission after discharge. Artificial intelligence (AI) based on wearable device data has shown great potential in the diagnosis and management of cardiovascular diseases.
This study aims to explore the clinical value of wearable device-based data analysis and AI-driven risk stratification models in post-...